{"id":"vincristine-carboplatin","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Neutropenia"},{"rate":"20-40%","effect":"Thrombocytopenia"},{"rate":"20-40%","effect":"Anemia"},{"rate":"50-70%","effect":"Nausea and vomiting"},{"rate":"30-50%","effect":"Diarrhea"},{"rate":"20-40%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL1351","moleculeType":"Small molecule","molecularWeight":"371.25"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to apoptosis in rapidly dividing cancer cells. Carboplatin, a platinum-based chemotherapy drug, works by cross-linking DNA, thereby inhibiting DNA replication and transcription, and inducing apoptosis in cancer cells.","oneSentence":"Vincristine is a vinca alkaloid that inhibits microtubule formation in the mitotic spindle, resulting in cell cycle arrest at the metaphase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:33.780Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute lymphoblastic leukemia"},{"name":"Hodgkin's lymphoma"},{"name":"Non-Hodgkin's lymphoma"},{"name":"Ovarian cancer"},{"name":"Small cell lung cancer"},{"name":"Testicular cancer"}]},"trialDetails":[{"nctId":"NCT04166409","phase":"PHASE3","title":"A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-01-31","conditions":"Low Grade Astrocytoma, Low Grade Glioma, Metastatic Low Grade Astrocytoma","enrollment":170},{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT03871257","phase":"PHASE3","title":"A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-01-15","conditions":"Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma","enrollment":165},{"nctId":"NCT02114229","phase":"PHASE2","title":"Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-14","conditions":"Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor","enrollment":125},{"nctId":"NCT06333899","phase":"EARLY_PHASE1","title":"Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion","status":"RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2025-08-03","conditions":"High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma","enrollment":15},{"nctId":"NCT06193759","phase":"PHASE1","title":"Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)","status":"RECRUITING","sponsor":"Children's National Research Institute","startDate":"2024-09-20","conditions":"Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes","enrollment":12},{"nctId":"NCT06401330","phase":"PHASE3","title":"A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-04-15","conditions":"Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor","enrollment":1656},{"nctId":"NCT07448480","phase":"","title":"Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"Blokhin's Russian Cancer Research Center","startDate":"2026-02-01","conditions":"Recurrent Malignant Glioma, Glioblastoma, Anaplastic Astrocytoma","enrollment":1000},{"nctId":"NCT04663347","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genmab","startDate":"2020-11-03","conditions":"Diffuse Large B-Cell Lymphoma, Follicular Lymphoma","enrollment":543},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT04322318","phase":"PHASE2","title":"A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-10-19","conditions":"Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor","enrollment":256},{"nctId":"NCT05504291","phase":"PHASE2","title":"A Study to Give Treatment Inside the Eye to Treat Retinoblastoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2022-11-04","conditions":"Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Group D Retinoblastoma","enrollment":26},{"nctId":"NCT05535166","phase":"PHASE2","title":"Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-12-20","conditions":"Medulloblastoma","enrollment":130},{"nctId":"NCT02875314","phase":"PHASE4","title":"HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parth Patel","startDate":"2015-09","conditions":"Medulloblastoma, Central Nervous System Embryonal Tumors","enrollment":250},{"nctId":"NCT06528496","phase":"PHASE2","title":"N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-07-22","conditions":"High-risk Neuroblastoma, Neuroblastoma, Childhood Neuroblastoma","enrollment":45},{"nctId":"NCT00336024","phase":"PHASE3","title":"Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-10-22","conditions":"Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":91},{"nctId":"NCT00602667","phase":"PHASE2","title":"Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-17","conditions":"Brain and Central Nervous System Tumors","enrollment":293},{"nctId":"NCT02870907","phase":"PHASE2","title":"Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2010-03-18","conditions":"Retinoblastoma","enrollment":195},{"nctId":"NCT06861244","phase":"PHASE2","title":"Embryonal Tumor With Multilayered Rosettes","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-06","conditions":"Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos","enrollment":70},{"nctId":"NCT03533582","phase":"PHASE3","title":"Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-24","conditions":"Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma","enrollment":537},{"nctId":"NCT07291102","phase":"PHASE3","title":"Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma","status":"NOT_YET_RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2026-07-01","conditions":"Medulloblastoma","enrollment":96},{"nctId":"NCT06520163","phase":"PHASE3","title":"Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2024-08-01","conditions":"Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization","enrollment":99},{"nctId":"NCT02066220","phase":"PHASE2, PHASE3","title":"International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2014-06","conditions":"Brain Tumors","enrollment":360},{"nctId":"NCT04681417","phase":"PHASE2, PHASE3","title":"Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome","status":"RECRUITING","sponsor":"Institut Curie","startDate":"2021-03-25","conditions":"Retinoblastoma","enrollment":225},{"nctId":"NCT02866136","phase":"PHASE2","title":"Conservative Treatments of Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2012-02","conditions":"Retinoblastoma, Children, Retinal Neoplasm","enrollment":133},{"nctId":"NCT00077285","phase":"PHASE2","title":"Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-10","conditions":"Sarcoma","enrollment":65},{"nctId":"NCT01096368","phase":"PHASE3","title":"Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2010-05-07","conditions":"Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma","enrollment":479},{"nctId":"NCT03786783","phase":"PHASE2","title":"Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-03-04","conditions":"Ganglioneuroblastoma, High Risk Neuroblastoma","enrollment":42},{"nctId":"NCT07187960","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-11","conditions":"Follicular Lymphoma","enrollment":228},{"nctId":"NCT00186888","phase":"PHASE3","title":"Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2005-04-07","conditions":"Retinoblastoma, Retinal Neoplasm","enrollment":107},{"nctId":"NCT07081022","phase":"PHASE2","title":"JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma","status":"RECRUITING","sponsor":"Shanghai Junshi Bioscience Co., Ltd.","startDate":"2025-08-17","conditions":"B-cell Non-Hodgkin's Lymphoma","enrollment":180},{"nctId":"NCT04947501","phase":"EARLY_PHASE1","title":"A Study of N9 Chemotherapy in Children With Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-06-22","conditions":"Neuroblastoma, Pediatric Cancer","enrollment":26},{"nctId":"NCT04221035","phase":"PHASE3","title":"High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2019-11-05","conditions":"High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy","enrollment":800},{"nctId":"NCT00392327","phase":"PHASE3","title":"Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2007-05-23","conditions":"Anaplastic Medulloblastoma, Medulloblastoma","enrollment":379},{"nctId":"NCT04478292","phase":"PHASE3","title":"A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy","status":"RECRUITING","sponsor":"Shanghai Children's Medical Center","startDate":"2021-03-01","conditions":"Hepatoblastoma","enrollment":330},{"nctId":"NCT04668365","phase":"PHASE2","title":"Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma","status":"SUSPENDED","sponsor":"Henan Cancer Hospital","startDate":"2020-12-25","conditions":"Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation","enrollment":59},{"nctId":"NCT03632135","phase":"PHASE3","title":"Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Cordgenics, LLC","startDate":"2018-05-20","conditions":"Recurrent Glioblastoma","enrollment":78},{"nctId":"NCT03669783","phase":"PHASE3","title":"Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2023-02-03","conditions":"Childhood Renal Tumor","enrollment":110},{"nctId":"NCT02299999","phase":"PHASE2","title":"SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2014-04-07","conditions":"Metastatic Breast Cancer","enrollment":1460},{"nctId":"NCT00554788","phase":"PHASE3","title":"Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-05-06","conditions":"Extraocular Retinoblastoma","enrollment":60},{"nctId":"NCT02455245","phase":"PHASE3","title":"A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alicia Lenzen","startDate":"2015-03","conditions":"Low Grade Glioma","enrollment":95},{"nctId":"NCT06669013","phase":"PHASE3","title":"Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas","status":"RECRUITING","sponsor":"N.N. Petrov National Medical Research Center of Oncology","startDate":"2021-05-20","conditions":"Bone Sarcoma, Embryonal Rhabdomyosarcoma, Alveolar Rhabdomyosarcoma","enrollment":40},{"nctId":"NCT05278715","phase":"PHASE2","title":"Modified CV Regimen in Optic Pathway Glioma","status":"RECRUITING","sponsor":"Beijing Sanbo Brain Hospital","startDate":"2022-04-13","conditions":"Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma","enrollment":75},{"nctId":"NCT01837862","phase":"PHASE1, PHASE2","title":"A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas","status":"COMPLETED","sponsor":"Julie Krystal","startDate":"2013-10-22","conditions":"Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic","enrollment":36},{"nctId":"NCT02348216","phase":"PHASE1, PHASE2","title":"Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Kite, A Gilead Company","startDate":"2015-04-21","conditions":"Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma (TFL)","enrollment":307},{"nctId":"NCT03017326","phase":"PHASE3","title":"Paediatric Hepatic International Tumour Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2017-08-24","conditions":"Hepatoblastoma, Carcinoma, Hepatocellular","enrollment":450},{"nctId":"NCT02265770","phase":"PHASE2, PHASE3","title":"An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2015-06-02","conditions":"Childhood Ependymoma","enrollment":536},{"nctId":"NCT00653068","phase":"PHASE3","title":"Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-02-10","conditions":"Childhood Atypical Teratoid/Rhabdoid Tumor","enrollment":70},{"nctId":"NCT00110110","phase":"PHASE2","title":"Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2004-06","conditions":"Retinoblastoma","enrollment":71},{"nctId":"NCT01783535","phase":"PHASE2","title":"Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-06-19","conditions":"Retinoblastoma","enrollment":174},{"nctId":"NCT01906814","phase":"PHASE3","title":"Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2013-08","conditions":"Retinoblastoma","enrollment":179},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT02684058","phase":"PHASE2","title":"Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-12-28","conditions":"Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma","enrollment":151},{"nctId":"NCT04659421","phase":"PHASE2","title":"Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas","status":"COMPLETED","sponsor":"Beijing Sanbo Brain Hospital","startDate":"2020-11-03","conditions":"Low-grade Glioma, Pediatric Brain Tumor","enrollment":60},{"nctId":"NCT00274924","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2006-09-26","conditions":"Lymphoma","enrollment":100},{"nctId":"NCT05834413","phase":"NA","title":"Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors","status":"NOT_YET_RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2023-05-01","conditions":"Lung Cancer","enrollment":367},{"nctId":"NCT00079417","phase":"PHASE3","title":"Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-12-26","conditions":"Intraocular Retinoblastoma","enrollment":28},{"nctId":"NCT02017964","phase":"PHASE2","title":"Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-12-24","conditions":"Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity","enrollment":26},{"nctId":"NCT02703272","phase":"PHASE3","title":"A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-07-01","conditions":"Lymphoma, Non-Hodgkin","enrollment":72},{"nctId":"NCT00712582","phase":"PHASE2","title":"Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2008-07-01","conditions":"Non-Hodgkin's Lymphoma","enrollment":96},{"nctId":"NCT02639650","phase":"PHASE3","title":"Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor","status":"UNKNOWN","sponsor":"Weiguo Lv","startDate":"2016-03-01","conditions":"Gestational Trophoblastic Neoplasms","enrollment":214},{"nctId":"NCT00567567","phase":"PHASE3","title":"Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-11-05","conditions":"Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma","enrollment":665},{"nctId":"NCT00867178","phase":"PHASE1","title":"Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-02-25","conditions":"Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":33},{"nctId":"NCT01542736","phase":"PHASE2","title":"Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET","enrollment":8},{"nctId":"NCT05080010","phase":"PHASE3","title":"Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-11-01","conditions":"Retinoblastoma","enrollment":500},{"nctId":"NCT00072384","phase":"PHASE3","title":"Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-04-16","conditions":"Intraocular Retinoblastoma","enrollment":30},{"nctId":"NCT00324467","phase":"PHASE2","title":"Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment","status":"UNKNOWN","sponsor":"British Columbia Cancer Agency","startDate":"2006-08","conditions":"Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma","enrollment":150},{"nctId":"NCT00002611","phase":"PHASE3","title":"Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1995-07","conditions":"Kidney Cancer","enrollment":3031},{"nctId":"NCT03986463","phase":"","title":"CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2019-05-01","conditions":"Lung Neoplasms, Lung Cancer, Neoplasm of Lung","enrollment":40},{"nctId":"NCT00335738","phase":"PHASE3","title":"Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-12","conditions":"Intraocular Retinoblastoma","enrollment":331},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT01704716","phase":"PHASE3","title":"High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)","status":"RECRUITING","sponsor":"St. Anna Kinderkrebsforschung","startDate":"2002-02","conditions":"Neuroblastoma","enrollment":3300},{"nctId":"NCT02445404","phase":"PHASE2","title":"Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2015-09-23","conditions":"Peripheral T-cell Lymphoma","enrollment":134},{"nctId":"NCT02116959","phase":"PHASE1","title":"Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2014-07-23","conditions":"Advanced Intra-Ocular Retinoblastoma, Retinoblastoma","enrollment":6},{"nctId":"NCT00500890","phase":"PHASE3","title":"Treatment of Tumors of the Choroid Plexus Epithelium","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2005-09-02","conditions":"Choroid Plexus Tumors","enrollment":2},{"nctId":"NCT01014767","phase":"PHASE3","title":"Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2009-11","conditions":"Brain Cancer, Choroid Plexus Tumors","enrollment":27},{"nctId":"NCT00027846","phase":"PHASE2","title":"Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-08","conditions":"Brain Tumor, Central Nervous System Tumor","enrollment":378},{"nctId":"NCT03715296","phase":"","title":"Lenalidomide Based Immunotherapy in the Treatment of DLBCL","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2018-10-18","conditions":"Diffuse Large B Cell Lymphoma","enrollment":200},{"nctId":"NCT00809341","phase":"PHASE2","title":"R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2009-01","conditions":"Non-Hodgkin's Lymphoma","enrollment":27},{"nctId":"NCT00077207","phase":"NA","title":"Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-07","conditions":"Brain Tumor, Central Nervous System Tumor","enrollment":66},{"nctId":"NCT00276640","phase":"NA","title":"Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"2004-04-01","conditions":"Primary Central Nervous System Neoplasms","enrollment":3417},{"nctId":"NCT00335556","phase":"PHASE2","title":"Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2006-06","conditions":"Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney","enrollment":291},{"nctId":"NCT01173887","phase":"PHASE2","title":"Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15","status":"COMPLETED","sponsor":"Kyowa Kirin Co., Ltd.","startDate":"2010-07","conditions":"Adult T-cell Leukemia-Lymphoma","enrollment":44},{"nctId":"NCT00980551","phase":"NA","title":"Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma","status":"WITHDRAWN","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2010-05","conditions":"Retinoblastoma","enrollment":""},{"nctId":"NCT03042429","phase":"PHASE3","title":"Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2007-01-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT00039195","phase":"PHASE2","title":"Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-11","conditions":"Lymphoma","enrollment":98},{"nctId":"NCT00003273","phase":"PHASE2","title":"Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"1997-11","conditions":"Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma","enrollment":""},{"nctId":"NCT00526318","phase":"NA","title":"Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2007-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT02471027","phase":"","title":"The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer","status":"UNKNOWN","sponsor":"Yu mei Wu","startDate":"2015-06","conditions":"Cervical Cancer","enrollment":1000},{"nctId":"NCT02319486","phase":"PHASE4","title":"CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2009-01","conditions":"Retinoblastoma","enrollment":26},{"nctId":"NCT02137928","phase":"PHASE3","title":"Carboplatin Periocular Injection for Retinoblastoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2006-01","conditions":"Retinoblastoma","enrollment":50},{"nctId":"NCT00003846","phase":"PHASE2","title":"Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-07","conditions":"Brain and Central Nervous System Tumors, Neuroblastoma","enrollment":25},{"nctId":"NCT00002610","phase":"PHASE3","title":"Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-01","conditions":"Kidney Cancer","enrollment":203},{"nctId":"NCT00002740","phase":"PHASE1","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-05","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT01535183","phase":"PHASE2","title":"Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2012-01","conditions":"Brain Tumor","enrollment":40},{"nctId":"NCT00030719","phase":"PHASE3","title":"Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-12","conditions":"Neuroblastoma","enrollment":175},{"nctId":"NCT00047138","phase":"PHASE3","title":"Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-01","conditions":"Kidney Cancer","enrollment":350},{"nctId":"NCT01899066","phase":"PHASE2","title":"Efficacy Study of Lucentis in the Treatment of Retinoblastoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2013-07","conditions":"Retinoblastoma","enrollment":20},{"nctId":"NCT00003141","phase":"PHASE1","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-03","conditions":"Brain Tumors, Central Nervous System Tumors, Neuroblastoma","enrollment":94}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"MALIGNANT NEOPLASM PROGRESSION"},{"count":2,"reaction":"OFF LABEL USE"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Oncovin + Paraplatin"],"phase":"phase_3","status":"active","brandName":"Vincristine, Carboplatin","genericName":"Vincristine, Carboplatin","companyName":"St. Jude Children's Research Hospital","companyId":"st-jude-children-s-research-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vincristine is a vinca alkaloid that inhibits microtubule formation in the mitotic spindle, resulting in cell cycle arrest at the metaphase. Used for Acute lymphoblastic leukemia, Hodgkin's lymphoma, Non-Hodgkin's lymphoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}